Department of Neurosurgery, Erasme Hospital, Université Libre de Bruxelles, Belgium.
Department of Neurosurgery, Erasme Hospital, Université Libre de Bruxelles, Belgium; Department of Neurosurgery, Ibn Tofail Hospital, Université Cadi Ayyad, CHU Mohammed Sixth, Marrakech, Morocco.
World Neurosurg. 2020 Dec;144:e380-e388. doi: 10.1016/j.wneu.2020.08.168. Epub 2020 Sep 3.
The coronavirus disease 2019 (COVID-19) pandemic is an unprecedented challenge. Different models of reorganization have been described aiming to preserve resources and ensure optimal medical care. Limited clinical neurosurgical experience with patients with COVID-19 has been reported. We share organizational experience, attitudes, and preliminary data of patients treated at our institution.
Institutional guidelines and patient workflow are described and visualized. A cohort of all neurosurgical patients managed during the lockdown period is presented and analyzed, assessing suspected nosocomial infection risk factors. A comparative surgical subcohort from the previous year was used to investigate the impact on surgical activity.
A total of 176 patients were admitted in 66 days, 20 of whom tested positive for COVID-19. Patients initially admitted to the neurosurgical ward were less likely to be suspected for a COVID-19 infection compared with patients admitted for critical emergencies, particularly with neurovascular and stroke-related diseases. The mortality of patients with COVID-19 was remarkably high (45%), and even higher in patients who underwent surgical intervention (77%). In addition to the expected decrease in surgical activity (-53%), a decrease in traumatic emergencies was noted.
By applying infection prevention and resource-sparing logistics measures shared by the international medical community, we were able to maintain essential neurosurgical care in a pandemic with controlled nosocomial infection risk. Special consideration should be given to medical management and surgical indications in patients infected with severe acute respiratory syndrome coronavirus 2, because they seem to show a problematic hemostatic profile that might result in an unfavorable clinical and surgical outcome.
2019 年冠状病毒病(COVID-19)大流行是一场前所未有的挑战。为了保存资源并确保最佳医疗护理,已经描述了不同的重组模式。有限的关于 COVID-19 患者的临床神经外科经验已有报道。我们分享在我们机构治疗的患者的组织经验、态度和初步数据。
描述和可视化机构指南和患者工作流程。介绍并分析了在封锁期间管理的所有神经外科患者的队列,并评估了疑似医院感染的危险因素。使用前一年的比较手术亚组来研究对手术活动的影响。
在 66 天内共收治了 176 名患者,其中 20 名 COVID-19 检测呈阳性。与因危急情况而入院的患者相比,最初被收治到神经外科病房的患者被怀疑感染 COVID-19 的可能性较小,尤其是患有神经血管和中风相关疾病的患者。COVID-19 患者的死亡率非常高(45%),而接受手术干预的患者的死亡率更高(77%)。除了手术活动(减少 53%)的预期下降外,创伤急症也有所减少。
通过应用国际医学界共享的感染预防和节省资源的后勤措施,我们能够在大流行期间维持基本的神经外科护理,同时控制医院感染的风险。应特别注意严重急性呼吸系统综合征冠状病毒 2 感染患者的医疗管理和手术指征,因为他们似乎表现出有问题的止血状况,这可能导致不利的临床和手术结果。